Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Of course. We are here to make money. The buzz is building my friend.
From VistaPartners two days ago in their newsletter. To access it, you go to their site and register for free:
"Soligenix, Inc. (SNGX)
Current Price: $1.94 Target Price: $7.00
• On June 23rd, Soligenix announced that it will be working with the National Organization for Rare Disorders (NORD) and the Cutaneous Lymphoma Foundation (CLF) to educate and recruit patients for its pivotal Phase 3 clinical study of SGX301 (synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL). SGX301 has previously been granted both orphan drug and fast track designations from the US Food and Drug Administration (FDA) for the first-line treatment of CTCL, a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system. NORD, the leading, independent nonprofit organization committed to the identification, treatment and cures of rare diseases, and CLF, an independent, nonprofit patient advocacy organization whose mission is to support patients with cutaneous lymphoma, will assist the Company in educating patients and raising awareness of the Phase 3 clinical trial among patients who are eligible for participation.
• The science behind the Company's prospective therapies has been and continues to be validated by a number of significant, important and influential entities such as government organizations and major pharmaceutical companies. To date, the Company has been awarded approximately $40 million mainly through BARDA, NIH and FDA grants/contracts. The Company has up to approximately $58 million in active government contract and grant funding still available to support its associated research programs through 2018.
• Soligenix has an exclusive worldwide collaboration deal with Intrexon Corporation (~$4.3B mkt cap) (NYSE: XON) to develop a novel passive immunotherapy for Melioidosis. Soligenix also has an exclusive commercial collaboration with SciClone Pharmaceuticals (~$455M mkt cap) (NASDAQ: SCLN) in China for SGX942 in the treatment of oral mucositis, a potentially billion dollar market."
Here is the link for the Zack's article posted today:
http://finance.yahoo.com/news/sngx-thermovax-addresses-critical-concerns-140000986.html;_ylt=AwrSbp2vn55Vmr0AMqJXNyoA;_ylu=X3oDMTExamZhajVjBGNvbG8DZ3ExBHBvcwMyBHZ0aWQDVUlDMV8xBHNlYwNzYw--
Wow!!! Thanks jbem as usual.
Looks like the selling is drying up. Buyers coming in.
Yup, exactly
No doubt $$$eeker. It's just there have been a lot of accusations that jbem is playing people but it's the furthest from the truth. Peter used jbem's properly and made a good buy.
Good job Peter!! That is the correct way to invest in jbem picks.
For those of you who got in at the high 1.70's/1.80's very nice.
True enough.
Good thoughts. I think you are right.
The overall market is certainly not helping that's for sure.
Totally agree.
Well, you are set then.
You buying?
Great buying opportunity right now.
It will turn around. Too much going on here. Too many catalysts. Very undervalued.
Yup. Success for everyone. Gltu.
I agree. But unlike tnxp, it's very low float. The turn around might be very quick IMO.
Maybe a bit of an understatement. Lol!!! I just feel it's going over $3 in the short term as well as being a great long term play. It's a low float stock with stacks of catalysts in the last half of the year. It's already turning around starting today. I love your DD. That DD is one of the reasons that I'm confident. Helped me greatly with AVXL as well when I bought it at .21. Now I still wish I owned it. Lol!!
As far as AVXL, this stock is rocking and shareholders should be very happy they own it right now. Gltu.
Yup. He is really solid. Sngx has had a little rough start but it's turning around. Take a look.
Good times. I'm actually very happy for everyone here. I'm not in avxl because I am elsewhere but there is good times here for sure.
That was a joke!!! Of course it's going up. Lol!!
But, with he OTC it gives investors the potential for great highs in the short term. Either way, this is where you want to be.
Agreed. There is tons of news the rest of this year. This is primed.
I think it could reach that. This is truly an undiscovered gem.
Today's move confirmed that .26 is still in play. Right 123tom?
True enough. Unlike yesterday, it bounced today. Hopefully, that is the reversal. Gltu.
No kidding!!! Normal trading was consolidation at $2.20 and then another move up. This seller overwhelmed the market.
SNGX--starting to turnaround.
Selling done? Maybe.
Usually, the buy zone is slightly between what the bashers and the pumpers say it is. On one hand its $1.50. On the other it was $2.20. We are in the $1.80/1.90's. About right.
Yes. It's actually a great fundamentally sound stock. The shorts say $1.50. The pumpers say $2.20 was a good buy. The reality is that $1.80's are the buy zone. Right between. No ever hits bottom or the top.
That is probably correct. However, with all that said, we are in the buy zone again. Hope people are taking advantage.
Yes, it has a diluted effect but it simply increases institutional ownership without the need to announce a offering. Pretty smart actually.
So you include unexercised shares in your calculation? Hmmm.
Smart move. The reality is that this was a $2.32 pps is October 2013 and they really haven't diluted much. They are much farther along now in their pipeline development. This is going way higher IMO.
Also, everyone points to an impending capital raise. That doesn't make sense either. If they needed a bunch more money they would have diluted more 6 months ago. Also, they have set up the Lincoln park financing to keep from having to dilute. We are good. If anything, today was a great buying opportunity.
Very well could be. The reality is that this was a $2.32 pps is October 2013 and they really haven't diluted much. They are much farther along now in their pipeline development. This is going way higher IMO.
Also, everyone points to an impending capital raise. That doesn't make sense either. If they needed a bunch more money they would have diluted more 6 months ago. Also, they have set up the Lincoln park financing to keep from having to dilute. We are good. If anything, today was a great buying opportunity.
SNGX--Just re-read their corporate presentation. There is a bundle of data and trial updates going to come out soon. This is the OTC, hold on.